Research Papers

Nanoparticle Mass Transfer From Lung Airways to Systemic Regions—Part II: Multi-Compartmental Modeling

[+] Author and Article Information
Arun V. Kolanjiyil

Department of Mechanical &
Aerospace Engineering,
North Carolina State University,
Raleigh, NC 27695

Clement Kleinstreuer

Department of Mechanical and
Aerospace Engineering,
North Carolina State University,
Raleigh, NC 27695;
Joint UNC-NCSU Department of
Biomedical Engineering,
North Carolina State University,
Raleigh, NC 27695
email: ck@ncsu.edu

1Corresponding author.

Contributed by the Bioengineering Division of ASME for publication in the Journal of Biomechanical Engineering. Manuscript received April 5, 2013; final manuscript received August 8, 2013; accepted manuscript posted September 6, 2013; published online October 9, 2013. Assoc. Editor: Naomi Chesler.

J Biomech Eng 135(12), 121004 (Oct 09, 2013) (12 pages) Paper No: BIO-13-1175; doi: 10.1115/1.4025333 History: Received April 05, 2013; Revised August 08, 2013; Accepted September 06, 2013

This is the second article of a two-part paper, combining high-resolution computer simulation results of inhaled nanoparticle deposition in a human airway model (Kolanjiyil and Kleinstreuer, 2013, “Nanoparticle Mass Transfer From Lung Airways to Systemic Regions—Part I: Whole-Lung Aerosol Dynamics,” ASME J. Biomech. Eng., 135(12), p. 121003) with a new multicompartmental model for insoluble nanoparticle barrier mass transfer into systemic regions. Specifically, it allows for the prediction of temporal nanoparticle accumulation in the blood and lymphatic systems and in organs. The multicompartmental model parameters were determined from experimental retention and clearance data in rat lungs and then the validated model was applied to humans based on pharmacokinetic cross-species extrapolation. This hybrid simulator is a computationally efficient tool to predict the nanoparticle kinetics in the human body. The study provides critical insight into nanomaterial deposition and distribution from the lungs to systemic regions. The quantitative results are useful in diverse fields such as toxicology for exposure-risk analysis of ubiquitous nanomaterial and pharmacology for nanodrug development and targeting.

Copyright © 2013 by ASME
Your Session has timed out. Please sign back in to continue.


Oberdörster, G., 1988, “Lung Clearance of Inhaled Insoluble and Soluble Particles,” J. Aerosol Med., 1(4), pp. 289–330. [CrossRef]
Kreyling, W., 1990, “Interspecies Comparison of Lung Clearance of “Insoluble” Particles,” J. Aerosol Med., 3(1), pp. 93–110. [CrossRef]
Kreyling, W. G., Semmler, M., and Möller, W., 2004, “Dosimetry and Toxicology of Ultrafine Particles,” J. Aerosol Med., 17(2), pp. 140–152. [CrossRef] [PubMed]
Geiser, M. and Kreyling, W. G., 2010, “Deposition and Biokinetics of Inhaled Nanoparticles,” Part. Fibre Toxicol, 7(2), pp. 1–17. [CrossRef] [PubMed]
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Lunts, A., Kreyling, W., and Cox, C., 2002, “Extrapulmonary Translocation of Ultrafine Carbon Particles Following Whole-Body Inhalation Exposure of Rats,” J. Toxicol. Environ. Health, Part A, 65(20), pp. 1531–1543. [CrossRef]
Geiser, M., Casaulta, M., Kupferschmid, B., Schulz, H., Semmler-Behnke, M., and Kreyling, W., 2008, “The Role of Macrophages in the Clearance of Inhaled Ultrafine Titanium Dioxide Particles.” Am. J. Respir. Cell Mol. Biol., 38(3), pp. 371–376. [CrossRef] [PubMed]
Brown, J. S., Zeman, K. L., and Bennett, W. D., 2002, “Ultrafine Particle Deposition and Clearance in the Healthy and Obstructed Lung,” Am. J. Respir. Crit. Care Med., 166(9), pp. 1240–1247. [CrossRef] [PubMed]
Klepczynska-Nyström, A., Sanchez-Crespo, A., Andersson, M., Falk, R., Lundin, A., Larsson, B., and Svartengren, M., 2012, “The Pulmonary Deposition and Retention of Indium-111 Labeled Ultrafine Carbon Particles in Healthy Individuals,” Inhalation Toxicol., 24(10), pp. 645–651. [CrossRef]
Mills, N. L., Amin, N., Robinson, S. D., Anand, A., Davies, J., Patel, D., Jesus, M., Cassee, F. R., Boon, N. A., and MacNee, W., 2006, “Do Inhaled Carbon Nanoparticles Translocate Directly Into the Circulation in Humans?,” Am. J. Respir. Crit. Care Med., 173(4), pp. 426–431. [CrossRef] [PubMed]
Möller, W., Felten, K., Sommerer, K., Scheuch, G., Meyer, G., Meyer, P., Häussinger, K., and Kreyling, W. G., 2008, “Deposition, Retention, and Translocation of Ultrafine Particles From the Central Airways and Lung Periphery,” Am. J. Respir. Crit. Care Med., 177(4), pp. 426–432. [CrossRef] [PubMed]
Nemmar, A., Hoet, P. H. M., Vanquickenborne, B., Dinsdale, D., Thomeer, M., Hoylaerts, M., Vanbilloen, H., Mortelmans, L., and Nemery, B., 2002, “Passage of Inhaled Particles Into the Blood Circulation in Humans,” Circulation, 105(4), pp. 411–414. [CrossRef] [PubMed]
Roth, C., Scheuch, G., and Stahlhofen, W., 1993, “Clearance of the Human Lungs for Ultrafine Particles,” J. Aerosol Sci., 24(,1), pp. S95-S96. [CrossRef]
Semmler, M., Seitz, J., Erbe, F., Mayer, P., Heyder, J., Oberdörster, G., and Kreyling, W., 2004, “Long-Term Clearance Kinetics of Inhaled Ultrafine Insoluble Iridium Particles From the Rat Lung, Including Transient Translocation Into Secondary Organs,” Inhalation Toxicol., 16(6-7), pp. 453–459. [CrossRef]
Semmler-Behnke, M., Takenaka, S., Fertsch, S., Wenk, A., Seitz, J., Mayer, P., Oberdörster, G., and Kreyling, W. G., 2007, “Efficient Elimination of Inhaled Nanoparticles From the Alveolar Region: Evidence for Interstitial Uptake and Subsequent Reentrainment Onto Airways Epithelium,” Environ. Health Perspect., 115(5), pp. 728–733. [CrossRef] [PubMed]
Takenaka, S., Karg, E., Kreyling, W., Lentner, B., Möller, W., Behnke-Semmler, M., Jennen, L., Walch, A., Michalke, B., and Schramel, P., 2006, “Distribution Pattern of Inhaled Ultrafine Gold Particles in the Rat Lung,” Inhalation Toxicol., 18(10), pp. 733–740. [CrossRef]
Kreyling, W., Semmler, M., Erbe, F., Mayer, P., Takenaka, S., Schulz, H., Oberdörster, G., and Ziesenis, A., 2002, “Translocation of Ultrafine Insoluble Iridium Particles From Lung Epithelium to Extrapulmonary Organs is Size Dependent but Very Low,” J. Toxicol. Environ. Health, Part A, 65(20), pp. 1513–1530. [CrossRef]
Ferin, J., Oberdörster, G., and Penney, D., 1992, “Pulmonary Retention of Ultrafine and Fine Particles in Rats.” Am. J. Respir. Cell Mol. Biol., 6(5), pp. 535–542. [CrossRef] [PubMed]
Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., Potter, R., Maynard, A., Ito, Y., and Finkelstein, J., 2006, “Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System,” Environ. Health Perspect., 114(8), pp. 1172–1178. [CrossRef] [PubMed]
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., and Cox, C., 2004, “Translocation of Inhaled Ultrafine Particles to the Brain,” Inhalation Toxicol., 16(6-7), pp. 437–445. [CrossRef]
Wang, J., Chen, C., Yu, H., Sun, J., Li, B., Li, Y., Gao, Y., He, W., Huang, Y., and Chai, Z., 2007, “Distribution of TiO 2 Particles in the Olfactory Bulb of Mice After Nasal Inhalation Using Microbeam SRXRF Mapping Techniques,” J. Radioanal. Nucl. Chem., 272(3), pp. 527–531. [CrossRef]
Enderle, J. D. and Bronzino, J. D., 2011, Introduction to Biomedical Engineering, Academic, New York.
ICRP, 1994, “Human Respiratory Tract Model for Radiological Protection,” Ann. ICRP, 24, pp. 1–3, Publication No. 66.
Tran, C., Jones, A., Cullen, R., and Donaldson, K., 1999, “Mathematical Modeling of the Retention and Clearance of Low-Toxicity Particles in the Lung,” Inhalation Toxicol., 11(12), pp. 1059–1076. [CrossRef]
Kuempel, E. D., O'Flaherty, E. J., Stayner, L. T., Smith, R. J., Green, F., and Vallyathan, V., 2001, “A Biomathematical Model of Particle Clearance and Retention in the Lungs of Coal Miners.” Regul. Toxicol. Pharmacol., 34(1), pp. 69–87. [CrossRef] [PubMed]
MacCalman, L., Tran, C., and Kuempel, E., 2009, “Development of a Bio-Mathematical Model in Rats to Describe Clearance, Retention and Translocation of Inhaled Nano Particles Throughout the Body,” J. Phys.: Conf. Ser., ed. 151, p. 012028. [CrossRef]
Sturm, R., 2007, “A Computer Model for the Clearance of Insoluble Particles From the Tracheobronchial Tree of the Human Lung,” Comput. Biol. Med., 37(5), pp. 680–690. [CrossRef] [PubMed]
Corley, R. A., Kabilan, S., Kuprat, A. P., Carson, J. P., Minard, K. R., Jacob, R. E., Timchalk, C., Glenny, R., Pipavath, S., and Cox, T., 2012, “Comparative Computational Modeling of Airflows and Vapor Dosimetry in the Respiratory Tracts of Rat, Monkey, and Human,” Toxicol. Sci., 128(2), pp. 500–516. [CrossRef] [PubMed]
Schroeter, J. D., Kimbell, J. S., Gross, E. A., Willson, G. A., Dorman, D. C., Tan, Y., and Clewell, H. J.III, 2008, “Application of Physiological Computational Fluid Dynamics Models to Predict Interspecies Nasal Dosimetry of Inhaled Acrolein,” Inhalation Toxicol., 20(3), pp. 227–243. [CrossRef]
Kolanjiyil, A. V. and Kleinstreuer, C., 2013, “Nanoparticle Mass Transfer From Lung Airways to Systemic Regions—Part I: Whole-Lung Aerosol Dynamics,” ASME J. Biomech. Eng., 135(12), p. 121003.
Kuempel, E. and Tran, C., 2002, “Comparison of Human Lung Dosimetry Models: Implications for Risk Assessment,” Ann. Occup. Hyg., 46(1), pp. 337–341. [CrossRef]
Brown, J. S., Wilson, W. E., and Grant, L. D., 2005, “Dosimetric Comparisons of Particle Deposition and Retention in Rats and Humans,” Inhalation Toxicol., 17(7-8), pp. 355–385. [CrossRef]
Kolanjiyil, A. V., 2013, “Deposited Nanomaterial Mass Transfer From Lung Airways to Systemic Regions,” M.S. thesis, North Carolina State University, Raleigh.
Zhu, M., Feng, W., Wang, Y., Wang, B., Wang, M., Ouyang, H., Zhao, Y., and Chai, Z., 2009, “Particokinetics and Extrapulmonary Translocation of Intratracheally Instilled Ferric Oxide Nanoparticles in Rats and the Potential Health Risk Assessment,” Toxicol. Sci., 107(2), pp. 342–351. [CrossRef] [PubMed]
Hofmann, W. and Asgharian, B., 2003, “The Effect of Lung Structure on Mucociliary Clearance and Particle Retention in Human and Rat Lungs,” Toxicol. Sci., 73(2), pp. 448–456. [CrossRef] [PubMed]
West, G. B., Brown, J. H., and Enquist, B. J., 1997, “A General Model for the Origin of Allometric Scaling Laws in Biology,” Science, 276(5309), pp. 122–126. [CrossRef] [PubMed]
Hill, A. V., 1950, “The Dimensions of Animals and Their Muscular Dynamics,” Sci. Prog., 38(150), pp. 209–230.
Dedrick, R. L., 1973, “Animal Scale-Up,” J. Pharmacokinet. Pharmacodyn., 1(5), pp. 435–461. [CrossRef]
Boxenbaum, H., 1982, “Interspecies Scaling, Allometry, Physiological Time, and the Ground Plan of Pharmacokinetics,” J. Pharmacokinet. Pharmacodyn., 10(2), pp. 201–227. [CrossRef]
Mordenti, J., 1986, “Man Versus Beast: Pharmacokinetic Scaling in Mammals,” J. Pharm. Sci., 75(11), pp. 1028–1040. [CrossRef] [PubMed]
Travis, C. C., White, R. K., and Ward, R. C., 1990, “Interspecies Extrapolation of Pharmacokinetics,” J. Theor. Biol., 142(3), pp. 285–304. [CrossRef] [PubMed]
U.S. Environmental Protection Agency, 1992, “Draft Report: A Cross-Species Scaling Factor for Carcinogen Risk Assessment Based on Equivalence of mg/Kg3/4/Day: Notice,” Fed. Regist., 57, pp. 21152–24173.
Dedrick, R., Bischoff, K., and Zaharko, D., 1970, “Interspecies Correlation of Plasma Concentration History of Methotrexate (NSC-740),” Cancer Chemother. Rep., 54(2), pp. 95–101. [PubMed]
Bailey, M., Kreyling, W., Andre, S., Batchelor, A., Collier, C., Drosselmeyer, E., Ferron, G., Foster, P., Haider, B., and Hodgson, A., 1989, “An Interspecies Comparison of the Lung Clearance of Inhaled Monodisperse Cobalt Oxide Particles—Part I: Objectives and Summary of Results,” J. Aerosol Sci., 20(2), pp. 169–188. [CrossRef]
Kreyling, W., Hodgson, A., Guilmette, R., Scarlett, C., Badmin, A., and Stradling, G., 1998, “Interspecies Comparison of Lung Clearance Using Monodisperse Terbium Oxide Particles,” Radiat. Prot. Dosimet., 79(1-4), pp. 241–243. [CrossRef]
Tran, C. L., Graham, M., and Buchanan, D., 2001, “A Biomathematical Model for Rodent and Human Lung Describing Exposure, Dose, and Response to Inhaled Silica,” Iom Research Report No. TM 4.
Seaton, A., Godden, D., MacNee, W., and Donaldson, K., 1995, “Particulate Air Pollution and Acute Health Effects,” Lancet, 345(8943), pp. 176–178. [CrossRef] [PubMed]


Grahic Jump Location
Fig. 1

Nanoparticle translocations from lung epithelium to regional lymph nodes, blood circulation, and secondary organs

Grahic Jump Location
Fig. 2

(a) Pictorial representation of the regional differentiation of a lung, and (b) multicompartment model structure describing the bio-kinetics of inhaled nanoparticles

Grahic Jump Location
Fig. 4

Comparison of amount of nanoparticle translocated to the olfactory bulb, calculated using the model with optimized parameter values for the complete lung, with experimental results

Grahic Jump Location
Fig. 3

Comparison of multicompartment model results, using optimized parameters, with experimental results: (a) normalized amounts of ultrafine particle retained in the lung, and (b) normalized amount of ultra-fine particle excreted from the lung

Grahic Jump Location
Fig. 5

Comparison of normalized retention profiles predicted by the multicompartment model with the experimental results of Takenaka et al. [16] after using a multiplication factor of 0.25

Grahic Jump Location
Fig. 6

Particle retention curves of rats and man as measured by Bailey et al. [43] and the retention curve extrapolated from the average values of HMT-rat, F344-rat, and SD-rat to human for: (a) 1.7μm particles, and (b) 0.8μm particles

Grahic Jump Location
Fig. 7

Particle retention curves of rat and man as measured by Kreyling et al. [44] and the retention curve extrapolated from rat to human

Grahic Jump Location
Fig. 8

Human lung retention fraction extrapolated from the rat lung retention fraction of Semmler et al. [13]

Grahic Jump Location
Fig. 9

Model simulation for the NP inhalation in a human: (a) NP retention fraction for 800 days, (b) NP retention fraction followed for 2 days after inhalation, (c) amount of NPs translocated to the blood circulation system, (d) amount (cumulative) of NPs translocated to other organs from the blood circulation system, (e) amount (cumulative) of NPs translocated to the lymphatic system, and (f) amount (cumulative) of NPs translocated to the olfactory lobe in brain

Grahic Jump Location
Fig. 10

Amount (cumulative) of ultrafine particles translocated to secondary organs through the blood circulation system




Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In